Latest filing published 14 Oct 2026 for Cue Biopharma, Inc., €27k.
Filing timeline
BuySaleInsider track record
Shao-Lee Lin: trading record in brief
Shao-Lee Lin has filed trades across 3 companies (mainly through SEC (Form 4)), most often in ACELYRIN, Inc., Horizon Therapeutics Public Ltd Co and Cue Biopharma, Inc. Between 4 January 2019 and 12 October 2026, the trades on record add up to 42 filings.
Sales make up the whole of the open-market record (10 sales, €1.9M). The rest of the record consists of 12 share grants and 5 option exercises. 2026 to date brings no purchases and 7 sales.
The latest filing, published on 14 October 2026, reports an open-market sale of €27k in Cue Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Shao-Lee Lin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,087 shares@ US$28.050.021% mcap1.6% of flowCommon StockSEC:0001725092-26-000019:1
- 10,000 shares@ US$27.500.19% mcap14.7% of flowCommon StockSEC:0001725092-26-000019:0
- 109,179 shares0Common StockSEC:0001725092-26-000013:0
- 34,225 shares@ US$26.990.64% mcap48.1% of flowCommon StockSEC:0001725092-26-000013:1
- 5,775 shares@ US$27.750.11% mcap8.3% of flowCommon StockSEC:0001725092-26-000013:2
- 5,423 shares@ US$27.190.10% mcap7.7% of flowCommon StockSEC:0001725092-26-000013:3
- 2,375 shares@ US$28.110.046% mcap3.5% of flowCommon StockSEC:0001725092-26-000013:4
- 10,460 shares@ US$29.480.21% mcap16.1% of flowCommon StockSEC:0001725092-26-000013:5
- 327,537 shares0Common StockSEC:0001725092-26-000006:0
- 9,961 shares@ US$6.628325.2% of flowCommon StockSEC:0001962918-24-000036:0
- 15,701 shares@ US$7.604845.4% of flowCommon StockSEC:0001962918-24-000015:0
- 10,691 shares@ US$7.40729.4% of flowCommon StockSEC:0001962918-24-000002:0
- 132,236 shares0Common StockSEC:0001962918-23-000036:1
- 1,161,747 shares0Common StockSEC:0001962918-23-000036:0
- 842,400 shares0Common StockSEC:0001962918-23-000021:0
- 337,179 shares@ US$24.6996.9% of flowCommon StockSEC:0001209191-23-028862:3
- 1,107,213 shares0Class A Common StockSEC:0001209191-23-028862:1
- 1,107,213 shares0Common StockSEC:0001209191-23-028862:2
- 677,813 shares0Class A Common StockSEC:0001209191-23-028862:4
- 677,813 shares0Common StockSEC:0001209191-23-028862:5
- 354,969 shares0Class A Common StockSEC:0001209191-23-028862:6
- 354,969 shares0Common StockSEC:0001209191-23-028862:7
- 354,969 shares0Class A Common StockSEC:0001209191-23-028862:8
- 354,969 shares0Common StockSEC:0001209191-23-028862:9
- 349,898 shares0Class A Common StockSEC:0001209191-23-028862:10
25 of 42 declarations